Results 11 to 20 of about 251,367 (400)
Trends in Microbiology, 2022 Acinetobacter baumannii is a ubiquitous, Gram-negative, nonflagellated coccobacillus bacterium commonly isolated from the environment. In human medicine, this opportunistic pathogen is responsible for hospital- and community-acquired infections. Resistance to last-resort antibiotics, such as colistin, tigecycline, and carbapenems, earns this bacterium ...
Clémence Whiteway +3 more
openaire +5 more sources
Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review
Infection and Drug Resistance, 2021 Alemu Gedefie,1 Wondmagegn Demsis,1 Melaku Ashagrie,1 Yeshimebet Kassa,1 Melkam Tesfaye,1 Mihret Tilahun,1 Habtye Bisetegn,1 Zenawork Sahle2 1Department of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie ...
Gedefie A +7 more
doaj +2 more sources
Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex
Clinical Infectious Diseases, 2023 Acinetobacter baumannii-calcoaceticus complex is the most commonly identified species in the genus Acinetobacter and it accounts for a large percentage of nosocomial infections, including bacteremia, pneumonia, and infections of the skin and urinary ...
M. Castanheira, R. Mendes, A. Gales
semanticscholar +1 more source
Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
Antibiotics, 2023 Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the treatment of infections caused by multidrug-resistant A.
K. Novović, B. Jovčić
semanticscholar +1 more source
A global view on carbapenem-resistant Acinetobacter baumannii
mBio, 2023 To give an update on the molecular epidemiology and global distribution of carbapenemase encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated from 114 study centers in 47 countries in five world regions, Africa, Asia ...
C. Müller +7 more
semanticscholar +1 more source
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Pathogens, 2021 Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates.
I. Kyriakidis +3 more
semanticscholar +1 more source
Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Nature Microbiology, 2021 We characterized two bacteriophages, ΦFG02 and ΦCO01, against clinical isolates of Acinetobacter baumannii and established that the bacterial capsule is the receptor for these phages.
F. G. Gordillo Altamirano +14 more
semanticscholar +1 more source
Frontiers in Microbiology, 2023 Acinetobacter is ubiquitous, and it has a high species diversity and a complex evolutionary pattern. To elucidate the mechanism of its high ability to adapt to various environment, 312 genomes of Acinetobacter strains were analyzed using the phylogenomic
Yang Zhao +4 more
semanticscholar +1 more source
Acinetobacter Metabolism in Infection and Antimicrobial Resistance
Infection and Immunity, 2023 Acinetobacter infections have high rates of mortality due to an increasing incidence of infections by multidrug-resistant (MDR) and extensively-drug-resistant (XDR) strains.
Xiaomei Ren, Lauren D. Palmer
semanticscholar +1 more source
Drug‑resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics (Review)
Experimental and Therapeutic Medicine, 2023 Bacterial drug resistance is increasingly becoming an important problem that needs to be solved urgently in modern clinical practices. Infection caused by Acinetobacter baumannii is a serious threat to the life and health of patients. The drug resistance
Hao Wu +7 more
semanticscholar +1 more source